Finally, if IL-33 abolishes NET protection extracellularly, it is possible that it exerts its biological effects acutely before its oxidation, pertinent to the close proximity of NETting neutrophils and pDCs in lupus-inflamed tissues (62, 63). The gene discussed is IL33; the disease is systemic lupus erythematosus.